Endobronchial malakoplakia in a young woman with rheumatoid arthritis: A case report

Liliana Fernández-Trujillo1,2, Luz F Sua2,3, Ana Isabel Castrillón4

  • 1Department of Internal Medicine, Pulmonology Service, Interventional Pulmonology. Fundación Valle del Lili, Cali, Colombia.

Science Progress
|February 26, 2026
PubMed

Insights

Pulmonary malakoplakia, a rare inflammatory lung condition, can mimic cancer. This case highlights its occurrence in an immunocompromised patient with rheumatoid arthritis, emphasizing diagnostic challenges and recurrence potential.

Area of Science:

  • Pulmonology
  • Pathology
  • Rheumatology

Background:

  • Malakoplakia is a rare inflammatory condition involving abnormal macrophage function.
  • Pulmonary malakoplakia is infrequent, typically seen in immunocompromised individuals.
  • It presents as granulomatous masses due to incomplete pathogen destruction.

Purpose of the Study:

  • To report a case of localized pulmonary malakoplakia in an immunocompromised patient.
  • To discuss the diagnostic challenges and clinical presentation of this rare condition.
  • To highlight treatment strategies and the potential for recurrence.

Main Methods:

  • Case presentation of a woman in her early 40s with rheumatoid arthritis.
  • Diagnostic evaluation including imaging and histopathology.
  • Histopathological confirmation of Michaelis-Gutmann bodies.

Main Results:

  • An endobronchial mass with neoplastic characteristics was identified.
  • Histopathology confirmed malakoplakia with Michaelis-Gutmann bodies.
  • The patient experienced disease recurrence one year after resection.

Conclusions:

  • Pulmonary malakoplakia poses diagnostic challenges due to its similarity to lung malignancies.
  • Accurate diagnosis requires histopathological examination, identifying Michaelis-Gutmann bodies.
  • Consider malakoplakia in immunocompromised patients with pulmonary masses, especially those lacking malignancy risk factors.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
155
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77